Vivian Laquer - Adherent Technologies (United States)

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 40 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Impact of Lebrikizumab on Vaccine-Induced Immune Responses: Results from a Phase 3 Study in Adult Patients with Moderate-to-Severe Atopic Dermatitis

Jennifer Soung,Vivian Laquer,Joseph F. Merola,Angela Moore,Hany Elmaraghy,Chaoran Hu,Maria Lucia Buziqui Piruzeli,Evangeline Pierce,Esther Garcia Gil, Abel D. Jarell

DERMATOLOGY AND THERAPYno. 8 (2024): 2181-2193

引用0浏览0WOS引用

Interim Results from ADmirable, a Phase 3b Open-Label Study Assessing Lebrikizumab in Patients with Skin of Color and Moderate-to-severe Atopic Dermatitis

Andrew Alexis, Ali Moiin,Jill Waibel, Paul Wallace,David Cohen,Vivian Laquer,Pearl Kwong,Amber Reck Atwater, Cynthia Harris, Jennifer Proper,Maria Silk,Evangeline Pierce,Sreekumar Pillai,Maria Jose Rueda,Angela Moore

BRITISH JOURNAL OF DERMATOLOGY (2024): 102-103

引用0浏览0引用

TAK-279, A SELECTIVE ORAL TYK2 INHIBITOR, REDUCES BSA INVOLVEMENT IN A PHASE 2B TRIAL IN MODERATE-TO-SEVERE PLAQUE PSORIASIS

Vivian Laquer,Leon Kircik,Neil Sadick,Jamie Weisman, Yi- wei Zhao,Jessamyn Blau,Wenwen Zhang, Jonathan Uy, Warren Winkelman,Melinda Gooderham

ACTA DERMATO-VENEREOLOGICA (2024)

引用0浏览0引用

51125 PATIENT EXIT INTERVIEWS ILLUSTRATE BENEFIT OF TRIFAROTENE ON ACNE-INDUCED PIGMENTARY PROBLEMS

Andrew Alexis,James Del Rosso,Seth Forman, Antonio Calatayud, John Browning,Vivian Laquer,J.P. York,Rajeev Chavda,Sunil Dhawan,Angela Moore,Linda Stein-Gold

Journal of the American Academy of Dermatologyno. 3 (2024): AB274

引用0浏览0引用

667 - Maintenance of Efficacy and Safety with Nemolizumab at Week 48: Results from Two Global Phase 3 Pivotal Studies (ARCADIA-1 and ARCADIA-2) in Patients with Moderate-to-severe Atopic Dermatitis

Jonathan I Silverberg,Andreas Wollenberg,Franz J Legat,Vivian T Laquer,April W Armstrong, Pedro Herranz,Luigi Naldi,Faiz Ahmad,Liliana Ulianov, Christophe Piketty

British Journal of Dermatologyno. Supplement_2 (2024)

引用0浏览0引用

Importance of Treating Acne Sequelae in Skin of Color: 6-Month Phase IV Study of Trifarotene with an Appropriate Skincare Routine Including UV Protection in Acne-Induced Post-Inflammatory Hyperpigmentation

Andrew Alexis,James Q. Del Rosso,Seth Forman,Antonio Martorell,John Browning,Vivian Laquer,Seemal R. Desai,Jean Philippe York,Rajeev Chavda,Sunil Dhawan,Angela Y. Moore,Linda Stein-Gold

INTERNATIONAL JOURNAL OF DERMATOLOGYno. 6 (2024): 806-815

引用0浏览0WOS引用

A Phase 2b, Randomized, Double-Blinded, Parallel-Group, Placebo-Controlled, International, Multicenter, Study to Evaluate the Efficacy and Safety of Rezpegaldesleukin in Adults with Moderate-to-severe Atopic Dermatitis

Melinda Gooderham,Charles Lynde,Maryam Shayesteh Alam,Neil Sadick,Craig A. Rohan,William Philip Werschler,Adelaide A. Hebert,Vivian T. Laquer,Maxwell Sauder, James Q. Del Rosso, Timothy Rodgers, Ricardo Tan, Stephen Schleicher,Dedee F. Murrell,Pablo Fernandez-Penas,Adam Reich,Spyridon Gkalpakiotis,Juan Ruano Ruiz,Andreas Wollenberg,Jacek C. Szepietowski,Michael Sticherling, Ansgar J. Weyergraf,Suzana Ljubojevic Hadzavdic, Wojciech Baran,Trinidad Montero Vilchez, Telegdy Eniko,Michael Sebastian, Sohail Chaudhry,Zachary Lee,Danni Yu, Yi Liu, Wang Waltz, Jenny Gilbert, Lucinda M. Elko-Simms,Christie Fanton, Charleen Jue,Mary Tagliaferri,Jonathan Zalevsky,David Rosmarin

BRITISH JOURNAL OF DERMATOLOGY (2024): 105-107

引用0浏览0引用

668 - Improvements in Itch and Sleep Disturbance Are Maintained Up to Week 48 with Nemolizumab Plus TCS/TCI Treatment in Patients with Moderate-to-severe Atopic Dermatitis: Results from Two Global Phase 3 Pivotal Studies (ARCADIA 1 and ARCADIA 2)

Jonathan I Silverberg,Andreas Wollenberg,Franz J Legat,Vivian T Laquer,Liliana Ulianov, Soo Yeon Cheong, Anna Ryzhkova, Christophe Piketty

British Journal of Dermatologyno. Supplement_2 (2024)

引用0浏览0引用

Maintenance of Efficacy and Safety with Nemolizumab at Week 48: Results from Two Global Phase 3 Pivotal Studies (ARCADIA-1 and ARCADIA-2) in Patients with Moderate-to-severe Atopic Dermatitis

Jonathan Silverberg,Andreas Wollenberg,Franz J. Legat,Vivian T. Laquer, April W. Armstrong, Pedro Herranz, Luigi Naldi, Faiz Ahmad,Liliana Ulianov,Christophe Piketty

BRITISH JOURNAL OF DERMATOLOGY (2024)

引用0浏览0引用

733 - Nemolizumab Elicits Fast Itch Response in Atopic Dermatitis Within 2 Days: a Post Hoc Analysis of ARCADIA 1 and 2 Data

Jonathan I Silverberg,Linda Stein-Gold,Diamant Thaçi, Andrew E Pink, Kim A Papp,Franz J Legat,Vivian T Laquer, Soo Yeon Cheong,Liliana Ulianov, Anna Ryzhkova, Christophe Piketty

British Journal of Dermatologyno. Supplement_2 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn